American Vietnamese Biotech Incorporation (HNX:AMV)
Vietnam · Delayed Price · Currency is VND 1,200.00
-100.00 (-7.69%)
At close: Aug 12, 2026
HNX:AMV Cash Flow Statement
Financials in millions VND. Fiscal year is January - December.
Millions VND. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Net Income | -71,166 | -72,637 | -11,191 | 10,685 | 53,931 | 82,240 |
Depreciation & Amortization | 18,199 | 22,421 | 23,945 | 21,832 | 20,399 | 15,877 |
Other Amortization | 17,621 | 11,448 | - | - | - | - |
Loss (Gain) From Sale of Assets | -604.44 | - | - | -1,365 | -546.84 | - |
Loss (Gain) From Sale of Investments | -3,142 | -3,142 | -11,949 | - | - | - |
Other Operating Activities | 24,810 | 48,233 | 24,629 | 5,230 | 7,951 | 408.69 |
Change in Accounts Receivable | 13,550 | 382,059 | 410,074 | -121,671 | -496,320 | -258,575 |
Change in Inventory | 3,411 | -2,783 | 237,134 | -11,168 | 67,769 | -272,042 |
Change in Accounts Payable | 55,054 | 4,367 | 2,010 | -41,177 | 303.52 | -4,781 |
Change in Other Net Operating Assets | -655.13 | -1,293 | 253.04 | -223.42 | 310.58 | -562.38 |
Operating Cash Flow | 57,077 | 388,673 | 674,905 | -137,858 | -346,202 | -437,435 |
Operating Cash Flow Growth | -93.80% | -42.41% | - | - | - | - |
Capital Expenditures | -16,328 | -16,328 | -46,375 | -6,934 | -1,485 | -73,459 |
Sale of Property, Plant & Equipment | - | - | 2,519 | 10,708 | 13,492 | - |
Investment in Securities | 40,662 | -288,093 | -623,720 | 144,013 | - | - |
Other Investing Activities | 792.63 | 540.39 | 114.47 | - | 1,102 | 3,482 |
Investing Cash Flow | -72,633 | -394,883 | -685,396 | 109,102 | 8,209 | -69,860 |
Long-Term Debt Issued | - | 46.99 | 9,660 | - | - | 145,000 |
Long-Term Debt Repaid | - | -5,046 | -21,813 | -4,580 | -12,788 | -14,599 |
Net Debt Issued (Repaid) | 7,500 | -4,999 | -12,153 | -4,580 | -12,788 | 130,401 |
Issuance of Common Stock | - | - | - | - | 399,748 | 379,620 |
Common Dividends Paid | - | - | - | -875.44 | - | - |
Financing Cash Flow | 7,500 | -4,999 | -12,153 | -5,455 | 386,959 | 510,022 |
Net Cash Flow | -8,057 | -11,209 | -22,645 | -34,212 | 48,966 | 2,727 |
Free Cash Flow | 40,749 | 372,344 | 628,530 | -144,792 | -347,688 | -510,894 |
Free Cash Flow Growth | -95.34% | -40.76% | - | - | - | - |
Free Cash Flow Margin | 39.79% | 233.20% | 202.52% | -73.66% | -123.37% | -228.24% |
Free Cash Flow Per Share | 310.93 | 2840.03 | 4794.07 | -1104.39 | -3236.32 | -6069.36 |
Levered Free Cash Flow | -149,024 | 322,536 | 534,786 | -107,752 | -353,159 | -546,725 |
Unlevered Free Cash Flow | -128,326 | 334,195 | 547,067 | -93,156 | -340,466 | -535,398 |
Cash Interest Paid | 14,030 | 15,086 | 13,502 | 14,714 | 15,576 | 10,060 |
Cash Income Tax Paid | 587.29 | 27.04 | 299.34 | 2,307 | 0.11 | 487.17 |
Change in Working Capital | 71,359 | 382,350 | 649,471 | -174,240 | -427,937 | -535,960 |